MLYS
Mineralys Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$28.21
−0.21%Leverage
- Debt / equity
- 0.18x
- Net debt / equity
- -0.07x
- Debt / assets
- 0.15x
- Debt / EBITDA
- -0.28x
- Net debt / EBITDA
- 0.12x
Liquidity & coverage
- Current ratio
- 34.46x
- Quick ratio
- 34.46x
- Cash ratio
- 34.24x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $646.5M
Cash & dividend
- FCF / debt
- -1.42x
- Cash flow / debt
- -1.42x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026